Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: A population-based cohort study.

International Journal of Cancer. Journal International Du Cancer
Raoul C ReulenMike M Hawkins

Abstract

Survivors of childhood cancer treated with cranial irradiation are at risk of cerebrovascular disease (CVD), but the risks beyond age 50 are unknown. In all, 13457 survivors of childhood cancer included in the population-based British Childhood Cancer Survivor Study cohort were linked to Hospital Episode Statistics data for England. Risk of CVD related hospitalisation was quantified by standardised hospitalisation ratios (SHRs), absolute excess risks and cumulative incidence. Overall, 315 (2.3%) survivors had been hospitalised at least once for CVD with a 4-fold risk compared to that expected (95% confidence interval [CI]: 3.7-4.3). Survivors of a central nervous system (CNS) tumour and leukaemia treated with cranial irradiation were at greatest risk of CVD (SHR = 15.6, 95% CI: 14.0-17.4; SHR = 5.4; 95% CI: 4.5-6.5, respectively). Beyond age 60, on average, 3.1% of CNS tumour survivors treated with cranial irradiation were hospitalised annually for CVD (0.4% general population). Cumulative incidence of CVD increased from 16.0% at age 50 to 26.0% at age 65 (general population: 1.4-4.2%). In conclusion, among CNS tumour survivors treated with cranial irradiation, the risk of CVD continues to increase substantially beyond age 50 u...Continue Reading

References

Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Feb 16, 2005·Cancer·Eva Steliarova-FoucherPeter Kaatsch
Oct 13, 2006·The New England Journal of Medicine·Kevin C OeffingerUNKNOWN Childhood Cancer Survivor Study
Nov 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel C BowersKevin C Oeffinger
Jun 28, 2007·JAMA : the Journal of the American Medical Association·Maud M GeenenFlora E van Leeuwen
Jul 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin C OeffingerGloria Lena Vega
Oct 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M van WaasM M van den Heuvel-Eibrink
Jul 16, 2010·JAMA : the Journal of the American Medical Association·Raoul C ReulenUNKNOWN British Childhood Cancer Survivor Study Steering Group
Sep 17, 2011·The Journal of Pediatrics·Julia SteinbergerK Scott Baker
Sep 13, 2012·Stroke; a Journal of Cerebral Circulation·Cynthia J CampenMichael J Fisher
Apr 30, 2013·International Journal of Radiation Oncology, Biology, Physics·Sabine MuellerHeather J Fullerton
May 18, 2013·International Journal of Radiation Oncology, Biology, Physics·Sabine MuellerKevin R Krull
Sep 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory T ArmstrongLillian R Meacham
Dec 4, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J ChowPaul J Martin
Dec 10, 2013·The Lancet Oncology·Gemma GattaUNKNOWN EUROCARE Working Group
Oct 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lee W JonesKevin C Oeffinger
Oct 31, 2014·Stroke; a Journal of Cerebral Circulation·James F MeschiaUNKNOWN Council on Hypertension
Feb 5, 2015·International Journal of Cancer. Journal International Du Cancer·Thorgerdur GudmundsdottirUNKNOWN ALiCCS study group
Feb 6, 2016·Journal of Stroke·Tackeun KimWon-Sang Cho
Jun 22, 2016·International Journal of Radiation Oncology, Biology, Physics·Irma W E M van DijkLeontien C M Kremer
Sep 3, 2016·BMJ : British Medical Journal·Miranda M FidlerUNKNOWN British Childhood Cancer Survivor Study Steering Group
Nov 20, 2016·Journal of the Neurological Sciences·João PassosDuarte Salgado
Dec 17, 2016·Stroke; a Journal of Cerebral Circulation·Eric E SmithUNKNOWN American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Functional Genom
Jan 10, 2017·International Journal of Radiation Oncology, Biology, Physics·Chiraz El-FayechFlorent de Vathaire
Feb 6, 2017·Circulation Research·Amelia K BoehmeMitchell S V Elkind
Mar 25, 2017·International Journal of Epidemiology·Annie HerbertPia Hardelid
Nov 3, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J ChowYutaka Yasui
Jun 7, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianLeontien C M Kremer

❮ Previous
Next ❯

Citations

Apr 23, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shelli R KeslerBrian J Nieman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.